Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Oct;23(10):1990-1997.
doi: 10.1038/mp.2017.165. Epub 2017 Aug 1.

Serotonin inputs to the dorsal BNST modulate anxiety in a 5-HT1A receptor-dependent manner

Affiliations

Serotonin inputs to the dorsal BNST modulate anxiety in a 5-HT1A receptor-dependent manner

A L Garcia-Garcia et al. Mol Psychiatry. 2018 Oct.

Abstract

Serotonin (5-HT) neurons project from the raphe nuclei throughout the brain where they act to maintain homeostasis. Here, we study 5-HT inputs into the bed nucleus of the stria terminalis (BNST), a major subdivision of the extended amygdala that has been proposed to regulate responses to anxiogenic environments in humans and rodents. While the dorsal part of the BNST (dBNST) receives dense 5-HT innervation, whether and how 5-HT in the dBNST normally modulates anxiety remains unclear. Using optogenetics, we demonstrate that activation of 5-HT terminals in the dBNST reduces anxiety in a highly anxiogenic environment. Further analysis revealed that optogenetic inhibition of 5-HT inputs into the dBNST increases anxiety in a less anxiogenic environment. We found that 5-HT predominantly hyperpolarizes dBNST neurons, reducing their activity in a manner that can be blocked by a 5-HT1A antagonist. Finally, we demonstrate that activation of 5-HT1A receptors in the dBNST is necessary for the anxiolytic effect observed following optogenetic stimulation of 5-HT inputs into the dBNST. These data reveal that 5-HT release in the dBNST modulates anxiety-like behavior via 5-HT1A receptors under naturalistic conditions.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1. Photostimulation of 5-HT terminals in the dBNST and CeA decreases new cage induced c-fos
(A) Diagram for new cage c-fos induction paradigm. (B) Representative images of c-fos staining in the dBNST (Top) and vBNST (Bottom) of control mice in home cage (Left) and in new cage (Center), and TPH-Chr2RPH-dBNST mice in new cage (Right). Scale bar=100 μm. (C) Photostimulation in TPH-Chr2RPH-dBNST mice reduces the number of c-fos positive cells in the dBNST but not in the vBNST in a new cage (one-way ANOVA dBNST: F1,6=35.877, p<0.01; vBNST: F1,6=1.257, p=0.3051) (n= 4–5/group). (D) Representative images of c-fos staining in the CeL (Top) and CeM (Bottom) of control mice in home cage (Left) and in new cage (Center), and TPH-Chr2RPH-CeA mice in new cage (Right). Scale bar=50 μm (E) Photostimulation in TPH-ChR2PHN-CeA mice results in fewer c-fos positive cells in the CeL and CeM in a new cage (one-way ANOVA CeL: F1,6=82.778, p<0.01; CeM: F1,6=34.508, p<0.01) (n= 4–5/group). Means are represented as ±SEM. (*p<0.05; **p<0.01). See also Supplementary Figure 1 and 6A, B.
Figure 2
Figure 2. Activation of 5-HT inputs into the dBNST results in anxiolysis
(A) Cartoon of TPH-ChR2RPH-dBNST mice with fiber optics implanted over dBNST. (B) TPH-ChR2RPH-dBNST mice spent more time in the center in the ON epoch compared to controls (two-way repeated measures ANOVA group x epoch interaction, F2,32=7.332, p=0.0024; post hoc Bonferroni corrected t-test, p<0.05). (C) No effect on total distance traveled in the open-field was observed (two-way repeated measures ANOVA group x epoch interaction, F2,32=0.614, p=0.5475). (D) TPH-ChR2RPH-dBNST mice spent more time in the open arms (two-way repeated measures ANOVA group x epoch interaction, F2,32=5.057, p=0.0124; post hoc Bonferroni corrected t-test, p<0.05) and (E) showed more open arm entries during photostimulation in the elevated-plus maze (two-way repeated measures ANOVA group x epoch interaction, F2,32=4.551, p=0.0182; post hoc Bonferroni corrected t-test, p<0.05). (F) Photostimulation of dBNST 5-HT inputs in TPH-ChR2RPH-dBNST mice decreased the latency to feed (two-way repeated measures ANOVA group x epoch interaction, F1,16=41.783, p<0.01; post hoc Bonferroni corrected t-test, p<0.05). (G) No changes in home cage (HC) consumption was observed (two-way repeated measures ANOVA group x epoch interaction, F1,16=0.540, p=0.4730). (n=8–10/group). Means are represented as ±SEM. (*p<0.05). See also Supplementary Figure 2 and 6A.
Figure 3
Figure 3. Activation of 5-HT terminals in the CeA has no effect on anxiety
(A) Diagram illustrating TPH-ChR2RPH-CeA mice. (B, C) No effect on center time (two-way repeated measures ANOVA group x epoch interaction, F2,22=0.043, p=0.9581) or total distance traveled in the open-field was observed (two-way ANOVA group x epoch interaction, F2,22=1.127, p=0.3420). (D, E) No differences were detected between TPH-ChR2RPH-CeA and control mice in time on the open arms (two-way repeated measures ANOVA group x epoch interaction, F2,22=0.026, p=0.9743) or open arm entries in the elevated-plus maze (two-way repeated measures ANOVA group x epoch interaction, F2,22=0.303, p=0.7417). (F) No effect was detected on latency to eat (two-way repeated measures ANOVA group x epoch interaction, F2,22=0.367, p=0.557) or (G) in home cage (HC) consumption (two-way repeated measures ANOVA group x epoch interaction, F2,22=0.287, p=0.6026). (n=6–7/group). Means are represented as ±SEM. See also Supplementary Figure 3 and 6B.
Figure 4
Figure 4. Inhibition of 5-HT inputs in the dBNST increases anxiety-like behaviors
(A) Diagram illustrating Pet-ArchRPH-dBNST mice. (B) Representative images of c-fos staining in the dBNST (Top) and vBNST (Bottom) of control mice in home cage (Left) and in new cage (Center), and Pet-ArchRPH-dBNST mice in new cage (Right). Scale bar=100 μm. (C) Green light illumination of Pet-ArchRPH-dBNST mice increases c-fos+ cells in the dBNST but not in the vBNST in a new cage (one-way ANOVA dBNST: F1,8=6.574, p<0.05; vBNST: F1,8=0.450, p=0.5214). (n=5/group) (D) During ON epochs, Pet-ArchRPH-dBNST mice spent significantly less time in the center (unpaired Student’s t test, OFF: DF=17, t=0.184, p=0.8656; ON: DF=17, t=2.416, p<0.05). (E) Group or light had no effect on total distance traveled in the open-field (unpaired Student’s t test, OFF: DF=17, t=0.013, p=0.9896; ON: DF=17, t=0.774, p=0.4670). (F) Pet-ArchRPH-dBNST mice spent less time in the open arms (unpaired Student’s t test, OFF: DF=17, t=0.290, p=0.7754; ON: DF=17, t=2.447, p<0.05) and (G) showed a lower number of entries into the open arms during the illumination epoch (unpaired Student’s t test, OFF: DF=17, t=0.421, p=0.6794; ON: DF=17, t=2.313, p<0.05). (n=8–11/group). Means are represented as ±SEM. (*p<0.05). See also Supplementary Figure 4 and 6C.
Figure 5
Figure 5. The behavioral effects of 5–HT release in the dBNST are mediated by activation of 5–HT1A receptors
(A) Model depiction of electrophysiological recordings. (B) Representative traces from electrophysiological recordings showing a delayed response to photostimulation of 5-HT inputs (20 Hz, 5 ms pulses for 15s) to dBNST neurons in TPH-CHR2 mice but not in controls or TPH-ChR2 mice pretreated with WAY 100,635. (C) Average magnitude of hyperpolarization in the dBNST neurons after photostimulation of 5-HT inputs (one-way ANOVA F2,19=21.152, p<0.01; Fisher post hoc TPH-ChR2 and control: p<0.01; TPH-ChR2 and TPH-ChR2+WAY: p<0.01) (n=7–8 cells/group). (D) Saline or the 5-HT1A receptor antagonist WAY 100,635 were locally infused into the dBNST of TPH-Chr2RPH-dBNST mice using a guide cannula 30 min before behavior. (E) TPH-Chr2RPH-dBNST mice pre-treated with WAY spend less time in the center of the open field during the ON epoch than the saline treated mice (two-way repeated measures ANOVA treatment x epoch interaction, F2.28=4.933, p=0.0146; post hoc Bonferroni corrected t-test, p<0.05). (F) No changes were detected in total distance traveled (two-way repeated measures ANOVA treatment x epoch interaction, F2.28=0.236, p=0.7193). (G) TPH-Chr2RPH-dBNST mice treated with WAY spend less time in the open arms (two-way repeated measures ANOVA treatment x epoch interaction, F2.28=11.326, p=0.0002; post hoc Bonferroni corrected t-test, p<0.05) and (H) show less open arm entries in the elevated-plus maze during the ON epoch when compared to saline treated mice (two-way repeated measures ANOVA treatment x epoch interaction, F2.28=4.100, p=0.0274; post hoc Bonferroni corrected t-test, p<0.05). (I) 5-HT1A antagonist injection into the dBNST attenuated the light-induced decrease in latency as seen after saline treatment (paired Student’s t test, DF=7, t=6.903, p=0.0002) with (J) no changes in home cage (HC) consumption (paired Student’s t test, DF=7, t=1.102, p=0.3451). (n=8/group). Means are represented as ±SEM. (*p<0.05; **p<0.01 vs. control or saline; ^^p<0.01 vs. WAY in recordings). See also Supplementary Figure 5 and 6D, E.

Similar articles

Cited by

References

    1. Griebel G. 5-Hydroxytryptamine-interacting drugs in animal models of anxiety disorders: more than 30 years of research. Pharmacology & therapeutics. 1995;65(3):319–395. - PubMed
    1. Avery SN, Clauss JA, Blackford JU. The Human BNST: Functional Role in Anxiety and Addiction. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. 2015 - PMC - PubMed
    1. Kim SY, Adhikari A, Lee SY, Marshel JH, Kim CK, Mallory CS, et al. Diverging neural pathways assemble a behavioural state from separable features in anxiety. Nature. 2013;496(7444):219–223. - PMC - PubMed
    1. Shackman AJ, Fox AS. Contributions of the Central Extended Amygdala to Fear and Anxiety. The Journal of neuroscience : the official journal of the Society for Neuroscience. 2016;36(31):8050–8063. - PMC - PubMed
    1. Alvarez RP, Chen G, Bodurka J, Kaplan R, Grillon C. Phasic and sustained fear in humans elicits distinct patterns of brain activity. NeuroImage. 2011;55(1):389–400. - PMC - PubMed

Publication types